• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Predictive models with the use of omics and supervised machine learning to diagnose non-alcoholic fatty liver disease: A "non-invasive alternative" to liver biopsy?

作者信息

Katsiki Niki, Gastaldelli Amalia, Mikhailidis Dimitri P

机构信息

First Department of Internal Medicine, Division of Endocrinology and Metabolism, Diabetes Center, Medical School, AHEPA University Hospital, Thessaloniki, Greece.

Cardiometabolic Risk Laboratory, Institute of Clinical Physiology, Pisa, Italy.

出版信息

Metabolism. 2019 Dec;101:154010. doi: 10.1016/j.metabol.2019.154010. Epub 2019 Nov 9.

DOI:10.1016/j.metabol.2019.154010
PMID:31711877
Abstract
摘要

相似文献

1
Predictive models with the use of omics and supervised machine learning to diagnose non-alcoholic fatty liver disease: A "non-invasive alternative" to liver biopsy?使用组学和监督式机器学习诊断非酒精性脂肪性肝病的预测模型：肝脏活检的“非侵入性替代方法”？
Metabolism. 2019 Dec;101:154010. doi: 10.1016/j.metabol.2019.154010. Epub 2019 Nov 9.
2
Non-invasive diagnosis of non-alcoholic steatohepatitis and fibrosis with the use of omics and supervised learning: A proof of concept study.基于组学和有监督学习的非酒精性脂肪性肝炎和肝纤维化的无创诊断：概念验证研究。
Metabolism. 2019 Dec;101:154005. doi: 10.1016/j.metabol.2019.154005. Epub 2019 Nov 9.
3
[Research advances in diagnosis of non-alcoholic fatty liver disease].非酒精性脂肪性肝病的诊断研究进展
Zhonghua Gan Zang Bing Za Zhi. 2017 Feb 20;25(2):115-118. doi: 10.3760/cma.j.issn.1007-3418.2017.02.007.
4
Liver fat deposition and mitochondrial dysfunction in morbid obesity: An approach combining metabolomics with liver imaging and histology.病态肥胖中的肝脏脂肪沉积和线粒体功能障碍：一种将代谢组学与肝脏成像和组织学相结合的方法。
World J Gastroenterol. 2015 Jun 28;21(24):7529-44. doi: 10.3748/wjg.v21.i24.7529.
5
A non-invasive prediction model for non-alcoholic steatohepatitis in paediatric patients with non-alcoholic fatty liver disease.非酒精性脂肪性肝病患儿非酒精性脂肪性肝炎的无创预测模型
Dig Liver Dis. 2014 Nov;46(11):1008-13. doi: 10.1016/j.dld.2014.07.016. Epub 2014 Aug 6.
6
Supervised learning reveals circulating biomarker levels diagnostic of hepatocellular carcinoma in a clinically relevant model of non-alcoholic steatohepatitis; An OAD to NASH.基于监督学习的方法，在非酒精性脂肪性肝炎向肝细胞癌进展的临床相关模型中，鉴定出循环生物标志物用于诊断肝细胞癌；OAD 向 NASH 的转变。
PLoS One. 2018 Jun 26;13(6):e0198937. doi: 10.1371/journal.pone.0198937. eCollection 2018.
7
Single non-invasive model to diagnose non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH).用于诊断非酒精性脂肪性肝病（NAFLD）和非酒精性脂肪性肝炎（NASH）的单一非侵入性模型。
J Gastroenterol Hepatol. 2014 Dec;29(12):2006-13. doi: 10.1111/jgh.12665.
8
Controversy in the diagnosis of pediatric non-alcoholic fatty liver disease.小儿非酒精性脂肪性肝病诊断中的争议
World J Gastroenterol. 2015 Jun 7;21(21):6444-50. doi: 10.3748/wjg.v21.i21.6444.
9
Diagnosis of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: Why liver biopsy is essential.非酒精性脂肪性肝病/非酒精性脂肪性肝炎的诊断：为何肝活检至关重要。
Liver Int. 2018 Feb;38 Suppl 1:64-66. doi: 10.1111/liv.13653.
10
Performance of non-invasive models of fibrosis in predicting mild to moderate fibrosis in patients with non-alcoholic fatty liver disease.非酒精性脂肪性肝病患者中无创性纤维化模型预测轻度至中度纤维化的性能。
Liver Int. 2016 Apr;36(4):572-9. doi: 10.1111/liv.13054. Epub 2016 Jan 24.

引用本文的文献

1
Metabolic Dysfunction Associated-Steatotic Liver Disease (MASLD) and Cardiovascular Risk: Embrace All Facets of the Disease.代谢功能障碍相关脂肪性肝病（MASLD）与心血管风险：全面认识该疾病的各个方面。
Curr Cardiol Rep. 2025 Jan 13;27(1):19. doi: 10.1007/s11886-024-02181-9.
2
Predicting Non-Alcoholic Steatohepatitis: A Lipidomics-Driven Machine Learning Approach.预测非酒精性脂肪性肝炎：一种基于脂质组学的机器学习方法。
Int J Mol Sci. 2024 May 29;25(11):5965. doi: 10.3390/ijms25115965.
3
The Cardiac-Kidney-Liver (CKL) syndrome: the "real entity" of type 2 diabetes mellitus.
心肾肝（CKL）综合征：2型糖尿病的“真实实体”。
Arch Med Sci. 2024 Jan 31;20(1):207-215. doi: 10.5114/aoms/183070. eCollection 2024.
4
Precision Medicine in Fatty Liver Disease/Non-Alcoholic Fatty Liver Disease.脂肪性肝病/非酒精性脂肪性肝病中的精准医学
J Pers Med. 2023 May 14;13(5):830. doi: 10.3390/jpm13050830.
5
Non-Alcoholic Fatty Liver Disease: Implementing Complete Automated Diagnosis and Staging. A Systematic Review.非酒精性脂肪性肝病：实现完全自动化诊断与分期。一项系统评价。
Diagnostics (Basel). 2021 Jun 12;11(6):1078. doi: 10.3390/diagnostics11061078.
6
Predicting and elucidating the etiology of fatty liver disease: A machine learning modeling and validation study in the IMI DIRECT cohorts.预测和阐明脂肪肝疾病的病因：在 IMI DIRECT 队列中进行机器学习建模和验证研究。
PLoS Med. 2020 Jun 19;17(6):e1003149. doi: 10.1371/journal.pmed.1003149. eCollection 2020 Jun.
7
Machine Learning Applications in Endocrinology and Metabolism Research: An Overview.机器学习在内分泌学和代谢研究中的应用：概述。
Endocrinol Metab (Seoul). 2020 Mar;35(1):71-84. doi: 10.3803/EnM.2020.35.1.71.